We serve Chemical Name:(2,4-difluoro-3-methoxycarbonylphenyl)boronic acid CAS:1190989-12-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2,4-difluoro-3-methoxycarbonylphenyl)boronic acid
CAS.NO:1190989-12-8
Synonyms:[2,4-Difluoro-3-(methoxycarbonyl)phenyl]boronic acid;x1653;Benzoic acid, 3-borono-2,6-difluoro-, methyl ester
Molecular Formula:C8H7BF2O4
Molecular Weight:215.947
HS Code:2931900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:370.0±52.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.497
PSA:66.76000
Exact Mass:216.040543
LogP:1.11
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like [2,4-Difluoro-3-(methoxycarbonyl)phenyl]boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoic acid, 3-borono-2,6-difluoro-, methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,x1653 Use and application,x1653 technical grade,usp/ep/jp grade.
Related News: A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. (2,4-difluoro-3-methoxycarbonylphenyl)boronic acid manufacturer Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said. (2,4-difluoro-3-methoxycarbonylphenyl)boronic acid supplier A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. (2,4-difluoro-3-methoxycarbonylphenyl)boronic acid vendor There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. (2,4-difluoro-3-methoxycarbonylphenyl)boronic acid factory In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.
